Bio-Techne Corporation
72.55USD
-0.0700 (-0.10%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TECH.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.45▲ | $0.44 | 1 | 0 |
| Next quarter | $0.48▼ | $0.48 | 1 | 0 |
| Current year | $2.04▼ | $2.05 | 2 | 0 |
| Next year | $2.31▲ | $2.3 | 3 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.52 | $0.52 | +0.00 (+0.1%) |
| 2026-03-31 | $0.53 | $0.53 | -0.00 (-0.8%) |
| 2025-12-31 | $0.43 | $0.46 | +0.03 (+5.8%) |
| 2025-09-30 | $0.42 | $0.42 | -0.00 (-0.4%) |
136 ratings from 23 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wells Fargo | Downgraded from Overweight | Equal-Weight | $62 $73 | Aug 13, 2026 |
| RBC Capital | Downgraded from Outperform | Sector Perform | $62 $73 | Jul 9, 2026 |
| TD Cowen | Downgraded from Buy | Hold | $65 $73 | Jun 30, 2026 |
| Benchmark | Downgraded from Buy | Hold | — | Jun 30, 2026 |
| Citigroup | Downgraded from Buy | Neutral | $70 $73 | Jun 29, 2026 |
| Stephens & Co. | Downgraded from Overweight | Equal-Weight | $68 $73 | Jun 26, 2026 |
| William Blair | Downgraded from Outperform | Market Perform | — | Jun 26, 2026 |
| Baird | Maintained | Neutral | $49 $73 | Jun 26, 2026 |
| Piper Sandler | Initiated | Neutral | $65 | Jun 11, 2026 |
| Citigroup | Maintained | Buy | $80 $70 | May 7, 2026 |
| Wells Fargo | Maintained | Overweight | $76 $62 | May 7, 2026 |
| Evercore ISI Group | Maintained | In-Line | $54 $50 | May 7, 2026 |
| Evercore ISI Group | Maintained | In-Line | $68 $54 | Apr 6, 2026 |
| Wells Fargo | Maintained | Overweight | $70 $76 | Feb 6, 2026 |
| Citigroup | Maintained | Buy | $70 $80 | Feb 5, 2026 |
| Stifel | Maintained | Hold | $60 $65 | Feb 5, 2026 |
| TD Cowen | Maintained | Buy | $70 $80 | Feb 5, 2026 |
| UBS | Maintained | Buy | $70 $79 | Feb 5, 2026 |
| Evercore ISI Group | Maintained | In-Line | $62 $68 | Feb 5, 2026 |
| Evercore ISI Group | Downgraded from Outperform | In-Line | $68 $62 | Jan 5, 2026 |
| Argus Research | Maintained | Buy | $65 $68 | Nov 20, 2025 |
| UBS | Maintained | Buy | $65 $70 | Nov 6, 2025 |
| Wells Fargo | Maintained | Overweight | $59 $70 | Nov 6, 2025 |
| TD Cowen | Maintained | Buy | $65 $70 | Oct 14, 2025 |
| Evercore ISI Group | Maintained | Outperform | $60 $72 | Oct 7, 2025 |
76 filings from 15 insiders · 16 buy / 1 sell over 6m
Officers and directors of TECH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| HIGGINS JOHN LDirector | ExerciseStock Options (Right to Buy) | 15.9k | — | — | Sep 28, 2026 |
| HIGGINS JOHN LDirector | Tax | 5.6k | $72.51 | $403k | Sep 28, 2026 |
| HIGGINS JOHN LDirector | Exercise | 15.9k | — | — | Sep 28, 2026 |
| BAUMGARTNER ROBERT VDirector | ExerciseStock Options (Right to Buy) | 15.9k | — | — | Sep 22, 2026 |
| BAUMGARTNER ROBERT VDirector | Tax | 5.6k | $72.55 | $403k | Sep 22, 2026 |
| BAUMGARTNER ROBERT VDirector | Exercise | 15.9k | — | — | Sep 22, 2026 |
| BOHNEN SHANEGeneral Counsel | Other | 4.3k | — | — | Aug 14, 2026 |
| HERR AMY E.Director | Otherindirect | 589 | — | — | Aug 14, 2026 |
| HIPPEL JAMESChief Financial Officer | Other | 9.8k | — | — | Aug 14, 2026 |
| KELDERMAN KIMChief Executive Officer | Other | 21.5k | — | — | Aug 14, 2026 |
| GEIST WILLIAMOfficer | Other | 6.4k | — | — | Aug 14, 2026 |
| CROUSE STEVEN C.Officer | Other | 5.4k | — | — | Aug 14, 2026 |
| HIPPEL JAMESChief Financial Officer | Exercise | 62.1k | $47.60 | $2.95M | Jul 29, 2026 |
| KELDERMAN KIMChief Executive Officer | Exercise | 35.0k | $47.60 | $1.67M | Jul 28, 2026 |
| BOHNEN SHANEGeneral Counsel | Exercise | 448 | $47.60 | $21k | Jul 23, 2026 |
| CROUSE STEVEN C.Officer | Other | 600 | — | — | Jun 2, 2026 |
| HERR AMY E.Director | Sellindirect | 6.6k | $48.28 | $320k | May 8, 2026 |
| HERR AMY E.Director | Exerciseindirect | 6.6k | $47.60 | $316k | May 8, 2026 |
| HIPPEL JAMESChief Financial Officer | Exercise | 62.0k | $47.60 | $2.95M | May 5, 2026 |
| KELDERMAN KIMChief Executive Officer | Exercise | 26.7k | $47.60 | $1.27M | May 5, 2026 |
No analyst notes on TECH yet.
Members whose judged calls on TECH have played out most reliably.
No settled calls on TECH yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
10 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 1 | 12 | 0 | 0 | Hold2.92 |
| 1 mo ago | 0 | 1 | 12 | 0 | 0 | Hold2.92 |
| 2 mo ago | 0 | 1 | 13 | 0 | 0 | Hold2.93 |
| 3 mo ago | 0 | 2 | 12 | 0 | 0 | Hold2.86 |